|
JPS5238680B2
(https=)
|
1972-12-27 |
1977-09-30 |
|
|
|
US4732155A
(en)
|
1985-08-27 |
1988-03-22 |
The Children's Medical Center Corporation |
Implantable chemoattractant system
|
|
US5658894A
(en)
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
|
US5661127A
(en)
|
1995-05-01 |
1997-08-26 |
The Regents Of The University Of California |
Peptide compositions with growth factor-like activity
|
|
JP3018313B2
(ja)
|
1996-02-23 |
2000-03-13 |
雪印乳業株式会社 |
骨形成促進及び骨吸収防止剤
|
|
US20040031072A1
(en)
*
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
EP1207879B1
(en)
|
1999-07-28 |
2009-08-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nicotine receptor agonists in stem cell and progenitor cell recruitment
|
|
CA2390053A1
(en)
|
1999-11-05 |
2001-05-10 |
Gerigene Medical Corporation |
Augmentation and repair of age-related soft tissue defects
|
|
EP1114862A3
(de)
|
1999-11-17 |
2003-08-06 |
Switch Biotech Aktiengesellschaft |
Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
|
|
CA2406864A1
(en)
|
2000-02-24 |
2001-08-30 |
Life Technologies Corporation |
Simultaneous stimulation and concentration of cells
|
|
JP3421741B2
(ja)
|
2000-05-18 |
2003-06-30 |
筑波大学長 |
人工骨髄、血球細胞の増殖方法
|
|
US7754217B2
(en)
|
2001-03-16 |
2010-07-13 |
Bio3 Research Srl |
HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
|
|
WO2002088181A2
(en)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
|
|
DE10121254A1
(de)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
|
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
EP1392844A4
(en)
|
2001-05-15 |
2006-09-06 |
Long Island Jewish Res Inst |
USE OF HMG FRAGMENTS AS ANTI-INFLAMMATORY AGENTS
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
AU2002366023B2
(en)
|
2001-11-19 |
2007-10-25 |
Kyowa Hakko Kirin Co., Ltd. |
Drug mobilizing pluripotent stem cells from tissue into peripheral blood
|
|
JP4653952B2
(ja)
|
2001-12-07 |
2011-03-16 |
サイトリ セラピューティクス インコーポレイテッド |
処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
|
|
FR2833609B1
(fr)
|
2001-12-19 |
2004-12-03 |
Natural Implant |
Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations
|
|
AU2003228099A1
(en)
|
2002-07-03 |
2004-01-23 |
Centro Cardiologico Monzino S.P.A.-Irccs |
Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair
|
|
AU2003236762A1
(en)
|
2002-07-05 |
2004-01-23 |
Universite Laval |
Chemotactic factor inhibitor for modulating inflammatory reactions
|
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
|
US20040156851A1
(en)
|
2002-11-20 |
2004-08-12 |
Critical Therapeutics, Inc. |
HMGB1 combination therapies
|
|
CA2506328A1
(en)
|
2002-11-20 |
2004-06-03 |
Critical Therapeutics, Inc. |
Use of hmgb fragments as anti-inflammatory agents
|
|
EP1579221A2
(de)
|
2003-01-03 |
2005-09-28 |
Alcedo Biotech GmbH |
Verwendungen von hmgb, hmgn, hmga proteinen
|
|
WO2004075855A2
(en)
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
CN1193092C
(zh)
|
2003-03-28 |
2005-03-16 |
浙江大学 |
骨髓间充质干细胞分离和体外扩增培养方法
|
|
WO2004084928A1
(en)
|
2003-03-28 |
2004-10-07 |
UNIVERSITé LAVAL |
S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
|
|
US20090069227A9
(en)
|
2003-04-29 |
2009-03-12 |
Capogrossi Maurizio C |
Use of HMGB1 to promote stem cell migration and/or proliferation
|
|
US20050014255A1
(en)
|
2003-05-29 |
2005-01-20 |
Board Of Regents, The University Of Texas System |
Stem cells for clinical and commercial uses
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
CA2882022A1
(en)
*
|
2003-09-11 |
2005-03-24 |
Walter Newman |
Monoclonal antibodies against hmgb1
|
|
ITRM20040058A1
(it)
|
2004-02-03 |
2004-05-03 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
|
|
EP1768693A1
(en)
|
2004-07-20 |
2007-04-04 |
Provincia Italiana Della Congregazione Dei Figli Dell'Immacolata Concezione - Istituto Dermopatico Dell'Immacolata |
Use of hmgb1 for wound healing
|
|
MX2007001155A
(es)
|
2004-07-29 |
2007-08-14 |
Creabilis Therapeutics Spa |
Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
|
|
NZ553809A
(en)
*
|
2004-09-03 |
2010-03-26 |
Creabilis Therapeutics Spa |
Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1
|
|
US7585504B2
(en)
|
2004-10-22 |
2009-09-08 |
Medimmune, Llc |
High affinity antibodies against HMGB1 and methods of use thereof
|
|
KR100593397B1
(ko)
|
2004-10-27 |
2006-06-28 |
한국원자력연구소 |
중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
|
|
WO2006047820A1
(en)
|
2004-11-01 |
2006-05-11 |
Newsouth Innovations Pty Limited |
Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
|
|
ITRM20050032A1
(it)
|
2005-01-21 |
2006-07-22 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
|
|
US9782439B2
(en)
|
2005-01-27 |
2017-10-10 |
Japan Health Sciences Foundation |
Cell sheet containing mesenchymal stem cells
|
|
MX2007011218A
(es)
|
2005-03-23 |
2007-10-17 |
Biosafe Sa |
Sistema integrado para colectar, procesar y transplantar subconjuntos de celulas, incluyendo celulas madre adultas para medicina regenerativa.
|
|
KR100775958B1
(ko)
*
|
2005-03-30 |
2007-11-13 |
김정문 |
조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법
|
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
|
US20100280493A1
(en)
|
2005-06-23 |
2010-11-04 |
Asha Nayak |
Methods and Systems for Treating Injured Cardiac Tissue
|
|
WO2007015546A1
(ja)
|
2005-08-04 |
2007-02-08 |
Genomix Co., Ltd |
間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
|
|
WO2007031100A1
(en)
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
WO2007061762A2
(en)
*
|
2005-11-18 |
2007-05-31 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt And Human Services |
Non-viral gene delivery complex
|
|
WO2007130725A2
(en)
|
2006-02-06 |
2007-11-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of hmgb1 for protection against ischemia reperfusion injury
|
|
JP4982739B2
(ja)
|
2006-06-01 |
2012-07-25 |
国立大学法人 東京医科歯科大学 |
ポリグルタミン病の予防・治療剤
|
|
TW200817437A
(en)
|
2006-08-11 |
2008-04-16 |
Medarex Inc |
Monoclonal antibodies against stromal cell derived factor-1 (SDF-1)
|
|
AU2007296843C1
(en)
|
2006-09-15 |
2012-08-16 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1
|
|
DE602007013919D1
(de)
*
|
2006-09-15 |
2011-05-26 |
Creabilis Therapeutics Spa |
Polymerkonjugate von box-a von hmgb1 und box-a-varianten von hmgb1
|
|
WO2008053892A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Genomix Co., Ltd. |
Pharmaceutical for promoting functional regeneration of damaged tissue
|
|
CA2629652A1
(en)
|
2007-04-24 |
2008-10-24 |
Yaojiong Wu |
Compositions for preventing or treating skin defects and methods of use thereof
|
|
US8114668B2
(en)
|
2007-05-14 |
2012-02-14 |
Cardiac Pacemakers, Inc. |
Composition for cold storage of stem cells
|
|
JP5660889B2
(ja)
|
2008-04-30 |
2015-01-28 |
株式会社ジェノミックス |
末梢循環への骨髄由来多能性幹細胞動員薬
|
|
EP2301560A4
(en)
|
2008-04-30 |
2012-05-09 |
Genomix Co Ltd |
PHARMACEUTICAL AGENT FOR PROMOTING THE FUNCTIONAL REGENERATION OF DEGRADED TISSUE
|
|
ES2654542T3
(es)
|
2008-04-30 |
2018-02-14 |
Genomix Co., Ltd. |
Procedimiento de recolección de células funcionales in vivo con alta eficiencia
|
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
|
US11191786B2
(en)
|
2009-10-28 |
2021-12-07 |
StemRIM Inc. |
Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood
|
|
CN102443064A
(zh)
|
2011-11-03 |
2012-05-09 |
刘誉 |
一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
|
|
DK2913059T3
(en)
|
2012-10-25 |
2018-06-25 |
Genomix Co Ltd |
Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT
|
|
AU2013335684B2
(en)
|
2012-10-25 |
2017-06-29 |
Osaka University |
Novel method for treating cardiac infarction using HMGB1 fragment
|